Early Diagnosis and Treatment Standardization of Delirium
NCT ID: NCT03199859
Last Updated: 2019-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2016-05-17
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Design a guideline for delirium, diagnosis or treatment
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MDD(Mild Cognitive Impairment Delirium Dementia) Cohort
NCT05113446
Delirium in Persons With Dementia
NCT01394328
Effect of Early Cognitive Stimulation Interventions on Delirium Among Critically Ill Patients
NCT06115863
Nursing Assistant Intervention to Prevent Delirium in Nursing Homes
NCT02994979
Delirium Detection During Routine Patient Care
NCT05836714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Second, Designing a guideline for treating delirium patients in Korea using the study data and reviewing other studies, guidelines.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncurable cancer
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bong-Jin Hahm
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
072016105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.